Status:
UNKNOWN
Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Macronutrient Composition to Improve Growth
Lead Sponsor:
Paracelsus Medical University
Collaborating Sponsors:
University Medical Center Rostock
Klinikum Südstadt, Rostock, Germany
Conditions:
Infant Development
Protein-energy; Imbalance
Eligibility:
MALE
23-32 years
Phase:
NA
Brief Summary
The purpose of this study is to measure protein turnover rates in preterm infants.
Detailed Description
After being informed about the study and potential risks, all parents giving written informed consent the principal investigator will determine the eligibility for study entry. Patients who met the el...
Eligibility Criteria
Inclusion
- Gestational age \< 32 weeks
- Enteral nutrition \>150 mL / kg / d
Exclusion
- gastrointestinal malformations
- Enterostoma
- short bowel syndrome
- necrotizing enterocolitis
- kidney disease
- Foreseeable transfer
Key Trial Info
Start Date :
April 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04854226
Start Date
April 21 2021
End Date
August 31 2024
Last Update
February 28 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Neugeborene, Kinder und Jugendliche Universitätsklinik der Paracelsus Medizinischen Privatuniversität
Nuremberg, Germany, 90471
2
Universitätsmedizin Rostock Kinder und Jugendklinik
Rostock, Germany, 18057
3
Klinikum Südstadt Rostock Abteilung für Neonatologie und Neonatologische Intensivmedizin
Rostock, Germany, 18059